Analyst Price Targets — ARNA
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 13, 2021 12:00 am | Chris Howerton | Jefferies | $100.00 | $90.08 | StreetInsider | Jefferies Downgrades Arena Pharma (ARNA) to Hold |
| September 27, 2021 12:00 am | Prakhar Agrawal | JonesTrading | $92.00 | $61.29 | Investing | JonesTrading Stick to Their Buy Rating for Arena Pharmaceuticals |
| May 18, 2021 12:00 am | Chris Shibutani | Goldman Sachs | $90.00 | $61.57 | TheFly | Arena Pharmaceuticals initiated with a Buy at Goldman Sachs |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
No recent news available for ARNA.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
